Skip to main content

Table 1 Characteristics of enrolled patients, and association with adherence assessed by the Morisky Medication Adherence Scalea [Total N 112]

From: Patient, clinician and logistic barriers to blood pressure control among adult hypertensives in rural district hospitals in Rwanda: a cross-sectional study

Socio-Demographic characteristics

N (%)

Adherence

p-value

High

Low-Mod

Gender

 Female

90 (80.4)

68 (75.6)

22 (24.4)

0.53

 Male

22 (19.6)

18 (81.8)

4 (18.2)

Age

 Age 22-59

48 (44.9)

36 (75)

12 (25)

0.88

 Age 60-90

59 (55.1)

45 (76.3)

14 (23.7)

Marital status

 Married

50 (44.6)

38 (76)

12 (24)

0.63

 Widow/er

54 (48.2)

41 (75.9)

13 (24.1)

 Separated

5 (4.4)

5 (100)

0 (0.0)

 Single

3 (2.6)

2 (66.7)

1 (33.3)

Alcohol Use

 Yes

13 (11.7)

10 (76.9)

3 (23.1)

0.98

 No

98 (88.3)

75 (76.5)

23 (23.5)

Tobacco Use

 Yes

6 (5.4)

5 (83.3)

1 (16.7)

0.69

 No

105 (94.6)

80 (76.2)

25 (23.8)

Education

 None

46 (41.4)

41 (89.1)

5 (10.9)

0.01

  < Primary

19 (17.1)

11 (57.9)

8 (42.1)

 Primary

40 (36)

29 (72.5)

11 (27.5)

  ≥ Secondary

6 (5.5)

4 (66.7)

2 (33.3)

Literacy

 Yes

64 (57.7)

44 (68.8)

20 (31.2)

0.01

 No

47 (42.3)

42 (89.4)

5 (10.6)

Health Insurance

 No

4 (3.6)

3 (75)

1 (25)

1

 Community

108 (96.4)

83 (76.9)

25 (23.1)

Occupation

 Farmer

102 (91.1)

78 (76.5)

24 (23.5)

1

 Private Sector

10 (8.9)

8 (80.0)

2 (20)

Clinical environment, clinical history, and clinical encounter

N (%)

High

Low-Mod

p-value

Hospital

 A

11 (9.8)

7 (63.6)

4 (36.4)

0.001

 B

31 (27.7)

18 (58.1)

13 (41.9)

 C

29 (25.9)

21 (72.4)

8 (27.6)

 D

41 (36.6)

40 (97.6)

1 (2.4)

Known Diagnosis of Hypertension

 Today

2 (1.8)

2 (100)

0 (0.0)

0.15

  < 1 Month

1 (0.9)

1 (100)

0 (0.0)

 1 Month to < 1 Year

43 (38.0)

37 (86.0)

6 (14.0)

 1 to 5 Years

32 (28.7)

25 (78.1)

7 (21.9)

 5 to 10 Years

18 (16.2)

11 (64.7)

6 (35.3)

  > 10 Years

16 (14.4)

9 (56.2)

7 (43.8)

BMI

  < 25

61 (66.3)

49 (80.3)

12 (19.7)

0.1

  ≥ 25

31 (33.7)

20 (64.5)

11 (35.5)

Target BP Achieved

 Yes

26 (29.2)

19 (73.1)

7 (26.9)

0.52

 No

63 (70.8)

50 (79.4)

13 (20.6)

Patient Received BP Feedback

 Yes

37 (33)

25 (67.6)

12 (32.4)

0.11

 No

75 (67)

61 (81.3)

14 (18.7)

Patient received Last Medication

 Yes

103 (94.5)

82 (79.6)

21 (20.4)

0.009

 No

6 (5.5)

2 (33.3)

4 (66.7)

Last Pharmacy Location

 N/A

5 (4.5)

3 (60)

2 (40)

0.004

 Hospital

102 (92.8)

81 (79.4)

21 (20.6)

 Private

3 (2.7)

0 (0.0)

3 (100)

Used Hospital Pharmacy Today

 Yes

102 (92.7)

82 (78.8)

22 (21.2)

0.06

 No

8 (7.3)

4 (50)

4 (50)

History of Anti-Hypertensive Medication Side Effects

 Yes

7 (6.6)

3 (42.9)

4 (57.1)

0.03

 No

103 (93.6)

81 (78.6)

22 (21.4)

  1. BMI body mass index, BP blood pressure, Mod moderate. All p-values calculated by chi squared test or by Fishers exact test for low expected cell frequencies, with significance as p < 0.05
  2. aThe MMAS (8-item) content, name, and trademarks are protected by US copyright and trademark laws. Permission for use of the scale and its coding is required. A license agreement is available from Donald E. Morisky, ScD, ScM, MSPH, 14725 NE 20th St Bellevue, WA 98007, USA; dmorisky@gmail.com. A score of 0 on the MMAS reflects high adherence